The mutational spectrum for the TP53 gene was investigated in a large series of bladder tumors and bladder tumor cell lines. Tumors and cell lines were screened for the presence of TP53 point mutations by single-strand conformational polymorphism analysis followed by direct sequencing. Mutations wer
Mutated and non-mutated TP53 as targets in the treatment of leukaemia
✍ Scribed by H. Nahi; G. Selivanova; S. Lehmann; L. Möllgård; S. Bengtzen; H. Concha; A. Svensson; K. G. Wiman; M. Merup; C. Paul
- Book ID
- 108675664
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 405 KB
- Volume
- 141
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Communicated by A. Jamie Cuticchia TP53 alteration is the most frequent genetic alteration found in human cancers. To date, more than 15,000 tumors with TP53 mutations have been published, leading to the description of more than 1,500 different TP53 mutants (http://p53.curie.fr). The frequency o
## Abstract Different mechanisms, such as chromosomal rearrangements, deletions, mutations, and methylation/demethylation of the promoter regions of genes, have been shown to be involved in acute lymphoblastic leukaemia (ALL). These genetic and epigenetic alterations lead to the activation of proto